F Hoffmann-La Roche has given marketing and development rights of BRAF inhibitor vemurafenib to Chugai Pharmaceutical. The licensing deal allows Roche to get milestone payments from Chugai Pharma.Chugai Pharma intends to begin a Phase I clinical trial for BRAF mutation-positive metastatic melanoma in Japan in 2012.Vemurafenib is being co-developed under a 2006 license and collaboration agreement between Roche and Plexxikon, a member of the Daiichi Sankyo Group.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
News
Medical Negligence in 2025: Pharma’s Role in Ensuring Patient Safety
In the ever-evolving world of healthcare, the role of...
News
When Pharma Meets the Underworld: How Legitimate Drug Supply Chains and Illicit Drug Markets Collide
In today's global landscape, the intersection between legitimate pharmaceutical...
News
Pharma’s Philanthropic Scrutiny: Navigating Charity Commission Investigations in Healthcare Giving
In the healthcare sector, the intersection of pharmaceutical companies...
News
Role of Combination Products is on the Rise in Biopharma
In the dynamic world of today, role of combination...
Latest stories
Previous article
Next article
Related stories
News
Medical Negligence in 2025: Pharma’s Role in Ensuring Patient Safety
In the ever-evolving world of healthcare, the role of...
News
When Pharma Meets the Underworld: How Legitimate Drug Supply Chains and Illicit Drug Markets Collide
In today's global landscape, the intersection between legitimate pharmaceutical...
News
Pharma’s Philanthropic Scrutiny: Navigating Charity Commission Investigations in Healthcare Giving
In the healthcare sector, the intersection of pharmaceutical companies...
News
Role of Combination Products is on the Rise in Biopharma
In the dynamic world of today, role of combination...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
